Quenelle
Mostrando 1-7 de 7 artigos, teses e dissertações.
-
1. Vida útil e avaliação sensorial de quenelle de tilápia durante o armazenamento em freezer
O objetivo deste trabalho foi avaliar a vida útil e os atributos sensoriais da quenelle de tilápia. Os tratamentos consistiram de dois tipos de embalagens - polietileno com zíper pouch (QA) e polietileno com caixa de papel cartão encerado (QB) - armazenadas a -18ºC por 120 dias. A quenelle de tilápia apresentou-se estável quanto aos parâmetros estabe
Pesq. agropec. bras.. Publicado em: 2013-08
-
2. Desenvolvimento do produto de conveniência Quenelle de tilápia (Oreochromis niloticus) / Product development of convenience quenelle tilapia (Oreochromis niloticus)
Para o desenvolvimento de um novo produto, busca-se atender a necessidade da indústria, do mercado e do consumidor, nos parâmetros qualidade, conveniência e com valor nutritivo que remeta à boa saúde. Com o objetivo de desenvolver o coproduto Quenelle de tilápia iniciou-se a etapa criativa de elaboração e a seguir, estabeleceu-se o processo do estudo
Publicado em: 2010
-
3. Oral Treatment of Cowpox and Vaccinia Virus Infections in Mice with Ether Lipid Esters of Cidofovir
American Society for Microbiology.
-
4. Efficacy of Microencapsulated Rifampin in Mycobacterium tuberculosis-Infected Mice
Rifampin is a first-line drug useful in the treatment of tuberculosis. By using biocompatible polymeric excipients of lactide and glycolide copolymers, two microsphere formulations were developed for targeted and sustained delivery of rifampin, with minimal dosing. A small-microsphere formulation, with demonstrated ability to inhibit intracellularly replicat
American Society for Microbiology.
-
5. Oral Treatment of Cowpox and Vaccinia Virus Infections in Mice with Ether Lipid Esters of Cidofovir
Four newly synthesized ether lipid esters of cidofovir (CDV), hexadecyloxypropyl-CDV (HDP-CDV), octadecyloxyethyl-CDV (ODE-CDV), oleyloxypropyl-CDV (OLP-CDV), and oleyloxyethyl-CDV (OLE-CDV), were found to have enhanced activities against vaccinia virus (VV) and cowpox virus (CV) in vitro compared to those of CDV. The compounds were administered orally and w
American Society for Microbiology.
-
6. Efficacy of Multiple- or Single-Dose Cidofovir against Vaccinia and Cowpox Virus Infections in Mice
Orthopoxviruses, including variola and monkeypox, pose risks to human health through natural transmission or potential bioterrorist activities. Since vaccination has not recently been utilized for control of these infections, there is renewed effort in the development of antiviral agents not only for postexposure smallpox therapy but also for treatment of ad
American Society for Microbiology.
-
7. Treatment of Tuberculosis Using a Combination of Sustained-Release Rifampin-Loaded Microspheres and Oral Dosing with Isoniazid
Previously, we reported on the use of rifampin-loaded microspheres to effectively treat Mycobacterium tuberculosis-infected macrophages and mice. Using similar biocompatible polymeric excipients of lactide and glycolide copolymers, we have increased the rifampin loading of small microsphere formulations (1 to 10 μm) by fourfold. Improved formulations were e
American Society for Microbiology.